Crinetics Pharmaceuticals IncNASDAQ:CRNX
- LAST PRICE50.5800
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots38.8800/ 1
- Ask / Lots51.2200/ 2
- Open / Previous Close--- / 50.5800
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRNX |
|---|---|---|
| 09:32 ET | 3747 | 50.56 |
| 09:34 ET | 2100 | 50.36 |
| 09:36 ET | 2134 | 50.59 |
| 09:38 ET | 10438 | 51.078 |
| 09:39 ET | 350 | 50.975 |
| 09:41 ET | 28266 | 51.34 |
| 09:43 ET | 1300 | 51.1 |
| 09:45 ET | 4760 | 51.305 |
| 09:48 ET | 1400 | 51.24 |
| 09:50 ET | 17169 | 51.22 |
| 09:52 ET | 6113 | 51.23 |
| 09:54 ET | 2218 | 51.275 |
| 09:56 ET | 2800 | 51.25 |
| 09:57 ET | 8491 | 51.43 |
| 09:59 ET | 1387 | 51.38 |
| 10:01 ET | 2425 | 51.59 |
| 10:03 ET | 2066 | 51.48 |
| 10:06 ET | 500 | 51.43 |
| 10:08 ET | 4500 | 51.405 |
| 10:10 ET | 800 | 51.325 |
| 10:12 ET | 700 | 51.28 |
| 10:14 ET | 3371 | 51.26 |
| 10:15 ET | 3595 | 51.21 |
| 10:17 ET | 2800 | 51.1 |
| 10:19 ET | 1200 | 51.05 |
| 10:21 ET | 1137 | 51.085 |
| 10:24 ET | 4011 | 51.11 |
| 10:26 ET | 11979 | 50.848 |
| 10:28 ET | 200 | 50.81 |
| 10:30 ET | 2800 | 50.88 |
| 10:32 ET | 650 | 51.01 |
| 10:33 ET | 1703 | 51.09 |
| 10:35 ET | 1200 | 51.16 |
| 10:37 ET | 4139 | 51.27 |
| 10:39 ET | 3500 | 51.45 |
| 10:42 ET | 1103 | 51.27 |
| 10:44 ET | 500 | 51.25 |
| 10:46 ET | 857 | 51.25 |
| 10:48 ET | 300 | 51.29 |
| 10:50 ET | 2165 | 51.255 |
| 10:51 ET | 181 | 51.24 |
| 10:53 ET | 600 | 51.25 |
| 10:55 ET | 1880 | 51.27 |
| 10:57 ET | 3565 | 51.19 |
| 11:00 ET | 800 | 51.125 |
| 11:02 ET | 1117 | 51.12 |
| 11:04 ET | 200 | 51.07 |
| 11:06 ET | 1631 | 51.205 |
| 11:08 ET | 100 | 51.2 |
| 11:09 ET | 150 | 51.24 |
| 11:11 ET | 100 | 51.295 |
| 11:13 ET | 1000 | 51.29 |
| 11:15 ET | 800 | 51.265 |
| 11:18 ET | 2320 | 51.2503 |
| 11:20 ET | 1895 | 51.2 |
| 11:22 ET | 300 | 51.12 |
| 11:24 ET | 3459 | 51.2 |
| 11:26 ET | 400 | 51.19 |
| 11:29 ET | 2705 | 51.212 |
| 11:31 ET | 1881 | 51.242 |
| 11:33 ET | 100 | 51.17 |
| 11:36 ET | 1649 | 51.15 |
| 11:38 ET | 400 | 51.15 |
| 11:40 ET | 500 | 51.145 |
| 11:42 ET | 25200 | 51.18 |
| 11:44 ET | 3012 | 51.08 |
| 11:45 ET | 3400 | 51.215 |
| 11:47 ET | 2116 | 51.21 |
| 11:49 ET | 5500 | 51.14 |
| 11:51 ET | 4059 | 51.06 |
| 11:54 ET | 1050 | 51.09 |
| 11:56 ET | 1400 | 51.05 |
| 11:58 ET | 2567 | 51.02 |
| 12:00 ET | 2038 | 51.03 |
| 12:02 ET | 2228 | 51.035 |
| 12:03 ET | 400 | 51.07 |
| 12:05 ET | 3201 | 51.05 |
| 12:09 ET | 427 | 51.08 |
| 12:12 ET | 5997 | 51.14 |
| 12:14 ET | 600 | 51.17 |
| 12:16 ET | 9097 | 51.11 |
| 12:18 ET | 1632 | 51.05 |
| 12:20 ET | 2134 | 51.15 |
| 12:21 ET | 375 | 51.14 |
| 12:23 ET | 900 | 51.06 |
| 12:25 ET | 248 | 51 |
| 12:32 ET | 444 | 50.99 |
| 12:34 ET | 1421 | 51.07 |
| 12:36 ET | 200 | 51.05 |
| 12:38 ET | 1150 | 51.1 |
| 12:39 ET | 200 | 51.085 |
| 12:41 ET | 1613 | 51.025 |
| 12:43 ET | 500 | 51.025 |
| 12:48 ET | 200 | 51.07 |
| 12:50 ET | 1566 | 51.04 |
| 12:52 ET | 3825 | 51.005 |
| 12:54 ET | 6059 | 50.875 |
| 12:56 ET | 200 | 50.805 |
| 12:57 ET | 2623 | 51 |
| 01:01 ET | 300 | 50.91 |
| 01:03 ET | 100 | 50.8279 |
| 01:06 ET | 591 | 51 |
| 01:08 ET | 300 | 50.91 |
| 01:10 ET | 800 | 50.96 |
| 01:12 ET | 8685 | 51 |
| 01:14 ET | 400 | 50.96 |
| 01:15 ET | 100 | 50.96 |
| 01:17 ET | 600 | 50.78 |
| 01:19 ET | 2200 | 50.755 |
| 01:21 ET | 1976 | 50.68 |
| 01:24 ET | 2400 | 50.66 |
| 01:26 ET | 2297 | 50.5501 |
| 01:28 ET | 1200 | 50.625 |
| 01:30 ET | 1256 | 50.75 |
| 01:33 ET | 100 | 50.71 |
| 01:35 ET | 100 | 50.69 |
| 01:37 ET | 4969 | 50.78 |
| 01:39 ET | 100 | 50.78 |
| 01:42 ET | 100 | 50.775 |
| 01:44 ET | 200 | 50.775 |
| 01:46 ET | 2700 | 50.84 |
| 01:48 ET | 100 | 50.89 |
| 01:51 ET | 700 | 50.9 |
| 01:53 ET | 600 | 50.84 |
| 02:00 ET | 700 | 50.8 |
| 02:02 ET | 951 | 50.815 |
| 02:04 ET | 400 | 50.82 |
| 02:08 ET | 2000 | 50.86 |
| 02:09 ET | 944 | 50.78 |
| 02:11 ET | 100 | 50.79 |
| 02:13 ET | 300 | 50.865 |
| 02:15 ET | 308 | 50.84 |
| 02:18 ET | 200 | 50.89 |
| 02:20 ET | 1200 | 50.83 |
| 02:24 ET | 100 | 50.81 |
| 02:26 ET | 1004 | 50.81 |
| 02:27 ET | 1700 | 50.89 |
| 02:31 ET | 1211 | 50.885 |
| 02:33 ET | 800 | 50.89 |
| 02:36 ET | 112 | 50.885 |
| 02:38 ET | 100 | 50.91 |
| 02:40 ET | 1705 | 50.92 |
| 02:42 ET | 319 | 50.915 |
| 02:44 ET | 1390 | 50.915 |
| 02:45 ET | 1766 | 50.95 |
| 02:47 ET | 100 | 50.955 |
| 02:49 ET | 1151 | 50.96 |
| 02:51 ET | 4210 | 50.94 |
| 02:54 ET | 1836 | 50.85 |
| 02:56 ET | 951 | 50.98 |
| 02:58 ET | 100 | 50.98 |
| 03:00 ET | 100 | 50.93 |
| 03:02 ET | 300 | 50.91 |
| 03:03 ET | 894 | 50.93 |
| 03:05 ET | 1570 | 50.925 |
| 03:09 ET | 1426 | 50.975 |
| 03:12 ET | 1267 | 51.03 |
| 03:14 ET | 2401 | 51 |
| 03:16 ET | 1543 | 51 |
| 03:18 ET | 1700 | 50.915 |
| 03:20 ET | 700 | 50.86 |
| 03:21 ET | 200 | 50.845 |
| 03:23 ET | 200 | 50.88 |
| 03:25 ET | 512 | 50.735 |
| 03:27 ET | 1501 | 50.79 |
| 03:30 ET | 113 | 50.76 |
| 03:32 ET | 370 | 50.74 |
| 03:34 ET | 2074 | 50.75 |
| 03:36 ET | 200 | 50.78 |
| 03:38 ET | 200 | 50.73 |
| 03:39 ET | 1100 | 50.81 |
| 03:41 ET | 1775 | 50.77 |
| 03:43 ET | 1100 | 50.74 |
| 03:45 ET | 2500 | 50.78 |
| 03:48 ET | 1300 | 50.75 |
| 03:50 ET | 1866 | 50.695 |
| 03:52 ET | 3444 | 50.685 |
| 03:54 ET | 4274 | 50.755 |
| 03:56 ET | 12591 | 50.82 |
| 03:57 ET | 8130 | 50.74 |
| 03:59 ET | 82216 | 50.58 |
Yesterday
Sep 16, 2024
DJ Crinetics Pharmaceuticals Price Target Maintained With a $90.00/Share by Cantor Fitzgerald, from 11:46AM ET on Monday Sep 16, 2024 by Dow Jones
11:46AM ET on Monday Sep 16, 2024 by Dow Jones
Sep 10, 2024
Crinetics Pharmaceuticals Announces September 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 4:40PM ET on Tuesday Sep 10, 2024 by Dow Jones
4:40PM ET on Tuesday Sep 10, 2024 by Dow Jones
Aug 29, 2024
Crinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences, from 4:05PM ET on Thursday Aug 29, 2024 by Dow Jones
4:05PM ET on Thursday Aug 29, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Crinetics Pharmaceuticals Inc | 4.0B | -13.4x | --- |
Immunovant Inc | 4.1B | -14.8x | --- |
BridgeBio Pharma Inc | 4.6B | -9.3x | --- |
Dyne Therapeutics Inc | 3.5B | -9.7x | --- |
Madrigal Pharmaceuticals Inc | 4.6B | -8.4x | --- |
Apogee Therapeutics Inc | 3.4B | -25.8x | --- |
Company Information
Crinetics Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its Paltusotine, an investigational, oral somatostatin receptor type 2 (SST2) agonist, is in Phase 3 clinical development for acromegaly and Phase 2 clinical development for carcinoid syndrome associated with neuroendocrine tumors. It has demonstrated pharmacologic proof-of-concept in a Phase 1 clinical study for CRN04894, an investigational, oral ACTH antagonist, that is in Phase 2 clinical studies for the treatment of congenital adrenal hyperplasia and Cushing's disease. Its drug candidates are orally delivered, small molecule new chemical entities resulting from in-house drug discovery efforts, including other programs addressing a variety of endocrine conditions such as hyperparathyroidism, polycystic kidney disease, Graves' disease, thyroid eye disease, diabetes and obesity.
Contact Information
- Headquarters
- 10222 Barnes Canyon Rd Bldg 2SAN DIEGO, CA, United States 92121-2711
- Phone
- 858-450-6464
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Wendell Wierenga
- Co-Founder, Director
- R. Scott Struthers
- Co-Founder, Chief Scientific Officer
- Stephen Betz
- Chief Financial Officer
- Marc Wilson
- Chief Operating Officer
- Jeff Knight
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.0B |
|---|---|
Revenue (TTM) | $1.4M |
Shares Outstanding | 80.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.64 |
EPS | $-3.77 |
Book Value | $7.91 |
P/E Ratio | -13.4x |
Price/Sales (TTM) | 2,922.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -20,068.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
